UK Coagulation Market, 2019-2023: Supplier Sales and Shares, Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Landscape

the new report designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities and develop effective strategies for the UK coagulation testing market during the next five years.

The report explores business and technological trends in the UK coagulation testing market; provides estimates of the test volume, as well as sales and market shares for leading instrument and reagent competitors; compares features of major analyzers; profiles leading market players; analyzes potential applications of emerging technologies; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Rationale

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the German coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

UK Market Overview

- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.
- Estimated universe of facilities performing coagulation tests.
- Five-year test volume and sales projections.

Business Opportunities and Strategic Recommendations

- Product development and business expansion opportunities with significant market appeal.
- “Ideal” product models with tentative prices and operating characteristics.
- Alternative market penetration strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.

Current and Emerging Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Sales and Market Share Analysis of Instrument and Reagent Suppliers

- Sales and market shares of major instrument and consumable manufactures.

Market Segmentation Analysis

- Comprehensive market segmentation analysis, including:

     - Hospitals
     - Commercial/Private Laboratories

- Test volume forecasts for over 40 major procedures, by market segment.

Current and Emerging Products

- Review of established and new procedures.

- Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Roche, Siemens, Sysmex and other suppliers.

Technology Review

- Analysis of current and emerging technologies and their potential market applications.

- Comprehensive lists of companies developing or marketing new technologies and products by test.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative coagulation testing technologies and products, including their sales, product portfolios,
marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

Abbott
Accriva
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Chrono-Log
Corgenix
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPHEN BioMed
Instrumentation Laboratory/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sienco
Sysmex
Thermo Fisher

I. Introduction
II. Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests

20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrands Factor
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their
Potential Applications
1. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
c. Sequencing
d. Microarrays/Biochips
2. Chromogenic Substrates
3. Monoclonal and Polyclonal Antibodies
4. Immunoassays
5. Microcomputers
6. Automation
7. Robotics
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
III. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument
and Reagent Suppliers Sales and Market Shares

IV. Major Product Development Opportunities
V. Design Criteria For Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
- Abbott
- ADI/American Diagnostica
- Alere/Biosite/Inverness
- Axis-Shield
- Beckman Coulter/Danaher
- Becton Dickinson

- Bio/Data
- Chrono-Log
- Corgenix Medical/Orgentec
- Diagnostica Stago/Trinity Biotech
- Grifols
- Helena Laboratories
- HYPEN BioMed
- Instrumentation Laboratory
- ITC/Nexus Dx
- Roche
- Siemens
- Sienco
- Sysmex
- Thermo Fischer
- ZyCare/Alere

List Of Tables

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation
Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator
Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests

Major Companies Developing or Marketing PT Tests

Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrands
Factor Tests

Executive Summary Table: U.K., Total Coagulation Diagnostics
Market By Market Segment and Product Category
U.K., Laboratories Performing Coagulation Tests By Market Segment
U.K., Hospital Laboratories Performing Coagulation Tests
By Bed Size
U.K., Commercial/Private Laboratories Performing Coagulation
Tests By Annual Test Volume
U.K., Hospital Laboratories Average Daily Test Volume
U.K., Commercial/Private Laboratories Average Daily Test Volume
U.K., Total Coagulation Test Volume By Market Segment
U.K., All Market Segments Coagulation Test Volume
U.K., Hospital Laboratories Coagulation Test Volume
U.K., Commercial/Private Laboratories Coagulation Test Volume

U.K., Coagulation Reagent Market By Market Segment
U.K., Major Suppliers of Coagulation Reagents Estimated Sales
and Market Shares


U.K., Coagulation Instrument Market By Market Segment
U.K., Major Suppliers of Coagulation Analyzers, Estimated
Instrument Sales and Market Shares
U.K., Total Coagulation Diagnostics Market By Product Category
U.K., Major Suppliers of Coagulation Diagnostic Products,
Estimated Sales and Market Shares

Fill The Form For Sample Request

Full Name *

Business Email *

E-mail *

Country * Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available